Navidea Biopharmaceuticals Inc (NAVB)
0.0381
0.00 (0.00%)
USD |
OTCM |
Apr 26, 13:29
Navidea Biopharmaceuticals Cash from Investing (Quarterly): -0.5247M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.5247M |
| June 30, 2023 | -0.065M |
| March 31, 2023 | -0.0394M |
| December 31, 2022 | -0.072M |
| September 30, 2022 | -0.0789M |
| June 30, 2022 | -0.1212M |
| March 31, 2022 | -0.1182M |
| December 31, 2021 | -0.0894M |
| September 30, 2021 | -0.1332M |
| June 30, 2021 | -0.0393M |
| March 31, 2021 | -0.0675M |
| December 31, 2020 | -0.0826M |
| September 30, 2020 | -0.2066M |
| June 30, 2020 | -0.0592M |
| March 31, 2020 | -0.0644M |
| December 31, 2019 | -0.058M |
| September 30, 2019 | 0.2015M |
| June 30, 2019 | 0.40M |
| March 31, 2019 | 0.2269M |
| December 31, 2018 | -0.0269M |
| September 30, 2018 | -0.0162M |
| June 30, 2018 | 0.5968M |
| March 31, 2018 | 0.40M |
| December 31, 2017 | 0.1977M |
| September 30, 2017 | -0.0232M |
| Date | Value |
|---|---|
| June 30, 2017 | -2.008M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.0374M |
| March 31, 2016 | -0.0018M |
| December 31, 2015 | -0.0086M |
| September 30, 2015 | -0.0019M |
| June 30, 2015 | -0.032M |
| March 31, 2015 | 0.0147M |
| December 31, 2014 | -0.0283M |
| September 30, 2014 | -0.3741M |
| June 30, 2014 | -0.1299M |
| March 31, 2014 | -0.9926M |
| December 31, 2013 | -0.5012M |
| September 30, 2013 | -0.1022M |
| June 30, 2013 | -0.3321M |
| March 31, 2013 | -0.3569M |
| December 31, 2012 | -0.0481M |
| September 30, 2012 | -0.2455M |
| June 30, 2012 | -0.2367M |
| March 31, 2012 | -0.1414M |
| December 31, 2011 | 0.067M |
| September 30, 2011 | 27.17M |
| June 30, 2011 | -0.0221M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.5247M
Minimum
Sep 2023
0.40M
Maximum
Jun 2019
-0.0677M
Average
-0.0698M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 7.427M |
| Senseonics Holdings Inc | 36.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.25M |
| Cash from Financing (Quarterly) | -0.1886M |
| Free Cash Flow | -9.907M |
| Free Cash Flow Per Share (Quarterly) | -0.1033 |
| Free Cash Flow Yield | -489.1% |